S. Lea (Manchester (Greater Manchester), United Kingdom), A. Spanevello (Milano, Italy)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Bronchial thermoplasty upregulates the expression of the glucocorticoid receptor in tissue sections
L. Zhou (Basel, Switzerland), L. Fang (Basel, Switzerland), E. Papakonstantinou (Basel, Switzerland), M. Tamm (Basel, Switzerland), M. Roth (Basel, Switzerland), D. Stolz (Basel, Switzerland)
|   |
Indacaterol acetate, glycopyrronium bromide, and mometasone furoate: effect on human airway inflammation
P. Rogliani (Roma (RM), Italy), B. Ritondo (Roma (RM), Italy), F. Facciolo (Roma (RM), Italy), I. Nikolaev (Basel (CH), Switzerland), L. Calzetta (Parma (PR), Italy)
| |
Effect of cigarette smoke extract and Th17 cytokine on production of inflammatory cytokines and chemokines in human airway smooth muscle cells
A. Alghamdi (Nottingham, United Kingdom), A. Alqarni (Nottingham, United Kingdom), M. Alahmari (Nottingham, United Kingdom), R. Edwards-Pritchard (Nottingham, United Kingdom), A. Tatler (Nottingham, United Kingdom), L. Pang (Nottingham, United Kingdom)
| |
Calcaratarin D attenuates house dust mite-induced allergic asthma
W. Liao (Singapore, Singapore), Y. Foo (Singapore, Singapore), W. Wong (Singapore, Singapore)
| |
The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.
I. Adcock (London, United Kingdom), M. Main (Castle Cary, United Kingdom), A. Rothaul (Oxford, United Kingdom), C. Wiegman (London, United Kingdom), F. Morgan (Medfield, United States of America)
| |
Indacaterol acetate, glycopyrronium bromide, and mometasone furoate: effect on neuronal inflammation and acetylcholine release
P. Rogliani (Roma (RM), Italy), B. Ritondo (Roma (RM), Italy), F. Facciolo (Roma (RM), Italy), M. Matera (Naples (NA), Italy), I. Nikolaev (Basel (CH), Switzerland), L. Calzetta (Parma (PR), Italy)
| |
Corticosteroid effects on airway neuroplasticity in experimental models of asthma
S. Rahmawati (Groningen, Netherlands), P. Goldsteen (Groningen, Netherlands), S. Bos (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), A. Dolga (Groningen, Netherlands), L. Kistemaker (Groningen, Netherlands), R. Gosens (Groningen, Netherlands)
| |
Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodeling
P. Esteves (PESSAC, France), L. Blanc (PESSAC, France), A. Celle (PESSAC, France), I. Dupin (PESSAC, France), E. Maurat (PESSAC, France), N. Amoedo (PESSAC, France), G. Cardouat (PESSAC, France), O. Ousova (PESSAC, France), L. Gales (TOULOUSE, France), F. Bellvert (TOULOUSE, France), H. Begueret (PESSAC, France), M. Thumerel (PESSAC, France), P. Girodet (PESSAC, France), R. Rossignol (PESSAC, France), P. Berger (PESSAC, France), T. Trian (PESSAC, France)
| |
Effect of intravenous alpha-1-antitrypsin augmentation therapy on proteinase-3-generated AaVal541 in deficient patients
I. Schouten (Leiden (ZH), Netherlands), A. Van Der Linden (Leiden (ZH), Netherlands), P. Hiemstra (Leiden (ZH), Netherlands), R. Mumford (Leiden (ZH), Netherlands), J. Stolk (Leiden (ZH), Netherlands)
| |
Adding glycopyrronium to beclomethasone/formoterol combination: synergistic effect on human small airways of COPD donors
L. Calzetta (Parma (PR), Italy), J. Ora (Rome (RM), Italy), A. Girolami (Rome (RM), Italy), I. Rossi (Rome (RM), Italy), I. De Guido (Rome (RM), Italy), F. Facciolo (Rome (RM), Italy), M. Cazzola (Rome (RM), Italy), P. Rogliani (Rome (RM), Italy)
| |
C-reactive protein and the type IV collagen measurementin severe COPD: Value of roflumilast
M. Ostrovskyy (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), G. Korzh (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine)
| |
Acupuncture regulates macrophage polarization in COPD mice model by activating dopamine D2 receptor.
T. Fan (Chengdu (Sichuan), China), X. Liu (Chengdu (Sichuan), China), Y. Zhang (Chengdu (Sichuan), China), Y. Lv (Chengdu (Sichuan), China), B. Mao (Chengdu (Sichuan), China)
| |
Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
M. Ostrovskyy (Ivano-Frankivsk, Ukraine), I. Savelikhina (Ivano-Frankivsk, Ukraine), K. Ostrovska (Ivano-Frankivsk, Ukraine), O. Varunkiv (Ivano-Frankivsk, Ukraine), M. Kulynych-Miskiv (Ivano-Frankivsk, Ukraine), G. Korzh (Ivano-Frankivsk, Ukraine), K. Shvets (Ivano-Frankivsk, Ukraine), N. Korzh (Ivano-Frankivsk, Ukraine)
| |
Late Breaking Abstract - Life cycle assessment (LCA) and cradle-to-grave carbon footprint of a multidose reservoirdry powder inhaler product family
V. Vartiainen (Espoo, Finland), A. Takala (Espoo, Finland), J. Haikarainen (Espoo, Finland), G. Parker (Hampshire, United Kingdom), T. Haahtela (Helsinki, Finland), T. Haahtela (Espoo, Finland)
| |
Late Breaking Abstract - Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD)
D. Price (Singapore, Singapore), W. Henley (Singapore, Singapore), V. Carter (Singapore, Singapore), D. Skinner (Singapore, Singapore), R. Vella (Singapore, Singapore), A. Papi (Ferrara, Italy), L. Fabbri (Ferrara, Italy), H. Kerstjens (Groningen, Netherlands), N. Roche (Paris, France), D. Singh (Manchester, United Kingdom), C. Vogelmeier (Marburg, Germany), E. Sen (Ankara, Turkey), J. Cançado (São Paulo, Brazil), E. Nudo (Parma, Italy), S. Barile (Parma, Italy), G. Georges (Parma, Italy)
| |
Late Breaking Abstract - Real world patient-reported outcomes in asthma across six European countries: the NEWTON study
F. Braido (Genoa, Italy), K. Beeh (Wiesbaden, Germany), S. Barile (Parma, Italy), C. Cisneros (Madrid, Spain), L. Cavalieri (Parma, Italy), A. Dinh-Xuan (Paris, France), E. Ingrassia (Parma, Italy), A. Piraino (Parma, Italy), L. Tamási (Budapest, Hungary), Y. Unal (Parma, Italy), R. Ulmeanu (Bucharest, Romania)
| |
Late Breaking Abstract - Efficacy and safety of eliapixant in refractory chronic cough: Results of the PAGANINI 12-week, randomized, placebo-controlled Phase 2b study
L. McGarvey (Belfast, United Kingdom), A. Morice (Hull, United Kingdom), J. Smith (Manchester, United Kingdom), M. Sher (Largo FL, United States of America), M. Vaezi (Nashville TN, United States of America), L. Guilleminault (Toulouse, France), A. Niimi (Nagoya, Japan), K. Roth (Berlin, Germany), R. Saarinen (Espoo, Finland), P. Vieira Pires (Wuppertal, Germany), M. Wosnitza (Wuppertal, Germany), P. Dicpinigaitis (Bronx NY, United States of America)
| |
Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma
A. Didier (Toulouse, France), C. Raherison-Semjen (Bordeaux, France), E. VERDIER (Lille, France), C. Camus (Toulouse, France), C. Pison (Grenoble, France), A. Bourdin (Montpellier, France), P. Bonniaud (Dijon, France), F. Blanc (Nantes, France), G. Devouassoux (Lyon, France), S. Fry (Lille, France), C. Nocent-Ejnaini (Bayonne, France), J. Courdeau-Labourie (Tarbes, France), C. Iamanadi (Mulhouse, France), A. Proust (Nîmes, France), J. Dot (Villeurbane, France), E. Auvray (Chambéry, France), F. Rolland (Cannes, France), S. Martinez (Aix-en-Provence, France), F. Hennegrave (Dunkerque, France), L. Portel (Libourne, France), P. Roux (Besançon, France), J. Miltgen (Toulon, France), M. Russier (Orléans, France), L. Guilleminault (Toulouse, France), C. Taillé (Paris, France)
| |
Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)
M. Lommatzsch (Rostock, Germany), S. Korn (Mainz, Germany), O. Schmidt (Koblenz, Germany), H. Timmermann (Hamburg, Germany), H. Watz (Grosshansdorf, Germany), A. Radwan (Tarrytown, United States of America), L. De Prado-Gomez (Reading, United States of America), A. Atenhan (Berlin, Germany), S. Barbus (Frankfurt, Germany), M. Thakur (Berlin, Germany)
| |